Zydus Lifesciences Financials
NSE: ZYDUSLIFE | BSE: 532321
₹1,119.10
As on 11-Sep-2026IST
Market cap
₹1,11,671 Cr
Revenue (TTM)
₹28,592 Cr
P/E Ratio
24.7
P/B Ratio
4.1
Div. Yield
0.1 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
28,591.70
|
27,148.40
|
23,241.50
|
19,547.40
|
17,237.40
|
15,109.90
|
|||||
|
Total Income
|
30,111.40
|
28,943.00
|
23,701.10
|
19,916.80
|
17,712.00
|
15,500.60
|
|||||
|
Total Expenditure
|
21,334.70
|
19,958.40
|
16,348.00
|
14,248.40
|
13,665.50
|
11,935.20
|
|||||
|
EBITDA
|
7,257.00
|
7,190.00
|
6,893.50
|
5,299.00
|
3,571.90
|
3,174.70
|
|||||
|
Depreciation
|
1,724.60
|
1,408.00
|
915.80
|
764.10
|
722.70
|
713.00
|
|||||
|
EBIT
|
5,532.40
|
5,782.00
|
5,977.70
|
4,534.90
|
2,849.20
|
2,461.70
|
|||||
|
Interest
|
510.20
|
438.90
|
191.00
|
81.20
|
129.90
|
127.00
|
|||||
|
Other Income
|
1,519.70
|
1,794.60
|
459.60
|
369.40
|
474.60
|
390.70
|
|||||
|
Exceptional Items
|
-534.80
|
-516.60
|
-219.60
|
-14.20
|
-604.20
|
112.70
|
|||||
|
Profit before Tax
|
6,007.10
|
6,621.10
|
6,026.70
|
4,808.90
|
2,589.70
|
2,838.10
|
|||||
|
Provision for Tax
|
1,514.90
|
1,594.70
|
1,411.90
|
977.50
|
587.80
|
511.70
|
|||||
|
Profit after Tax
|
4,492.20
|
5,026.40
|
4,614.80
|
3,831.40
|
2,001.90
|
2,326.40
|
|||||
|
Minority Interest
|
-79.70
|
-83.50
|
-147.10
|
-113.30
|
-131.60
|
-131.00
|
|||||
|
Share of Associate
|
100.50
|
97.10
|
57.80
|
118.40
|
94.60
|
46.20
|
|||||
|
Consolidated Profit
|
4,513.00
|
5,040.00
|
4,525.50
|
3,859.50
|
1,960.30
|
4,487.30
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
27,111.40
|
27,111.40
|
23,953.10
|
19,829.50
|
17,515.80
|
16,999.60
|
|||||
|
Minority Interest
|
-79.70
|
2,470.80
|
2,405.30
|
2,272.10
|
2,172.50
|
2,054.20
|
|||||
|
Non-Current Liabilities
|
7,112.50
|
5,003.90
|
-542.10
|
193.10
|
-725.00
|
-193.60
|
|||||
|
Current Liabilities
|
15,711.90
|
15,711.90
|
9,041.60
|
5,339.70
|
5,526.70
|
7,826.80
|
|||||
|
Total Liabilities
|
52,406.60
|
50,672.60
|
36,689.10
|
28,834.30
|
25,562.00
|
27,641.60
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
31,677.20
|
30,391.90
|
17,811.80
|
16,135.20
|
14,477.60
|
14,438.20
|
|||||
|
Current Assets
|
19,906.10
|
19,906.10
|
17,046.10
|
11,419.80
|
10,008.20
|
12,095.20
|
|||||
|
Total Assets
|
52,406.60
|
50,672.60
|
36,689.10
|
28,834.30
|
25,562.00
|
27,641.60
|
|||||
|
Total Debt*
|
--
|
11,769.50
|
3,169.50
|
768.60
|
1,163.20
|
4,196.00
|
|||||
|
Net Current Assets
|
4,194.20
|
4,194.20
|
8,004.50
|
6,080.10
|
4,481.50
|
4,268.40
|
|||||
|
Contingent Liabilities
|
--
|
989.90
|
731.80
|
753.20
|
801.10
|
655.60
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
2,116.60
|
6,781.10
|
3,196.30
|
2,688.80
|
2,104.50
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-8,296.10
|
-8,357.80
|
-1,475.20
|
1,535.00
|
-1,000.30
|
|||||
|
Cash from Financing Activities
|
--
|
5,806.90
|
1,995.30
|
-1,778.80
|
-4,400.40
|
-868.30
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-372.60
|
418.60
|
-57.70
|
-176.60
|
235.90
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
49.00
|
50.10
|
44.99
|
38.36
|
19.37
|
43.82
|
|||||
|
Cash EPS (₹)
|
45.24
|
63.96
|
54.98
|
45.68
|
26.92
|
29.68
|
|||||
|
Adjusted Book Value (₹)
|
270.31
|
269.50
|
238.10
|
197.11
|
173.08
|
166.01
|
|||||
|
Dividend per Share (₹)
|
0.09
|
1.00
|
11.00
|
3.00
|
6.00
|
2.50
|
|||||
|
Cash Flow per Share (₹)
|
--
|
21.04
|
67.41
|
31.77
|
26.57
|
20.55
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
4.14
|
53.41
|
27.70
|
14.41
|
14.88
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
21.39
|
26.06
|
24.90
|
13.64
|
15.30
|
|||||
|
ROE (%)
|
18.78
|
19.69
|
21.08
|
20.52
|
11.60
|
15.51
|
|||||
|
ROA (%)
|
10.03
|
11.81
|
14.77
|
14.70
|
7.82
|
9.40
|
|||||
|
EBIT Margin (%)
|
19.35
|
21.30
|
25.72
|
23.20
|
16.53
|
16.29
|
|||||
|
Net Margin (%)
|
14.92
|
17.37
|
19.47
|
19.24
|
11.30
|
15.01
|
|||||
|
Cash Profit Margin (%)
|
--
|
12.45
|
12.11
|
12.12
|
8.03
|
10.28
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
21.11
|
16.81
|
18.90
|
13.40
|
14.08
|
4.90
|
|||||
|
EBIT Growth (%)
|
-8.99
|
-3.27
|
31.82
|
59.16
|
15.74
|
-9.35
|
|||||
|
Net Profit Growth (%)
|
4.14
|
8.92
|
20.45
|
91.39
|
-13.95
|
5.48
|
|||||
|
EPS Growth (%)
|
-1.13
|
11.37
|
17.26
|
98.06
|
-55.80
|
110.32
|
|||||
|
Book Value Growth (%)
|
--
|
13.19
|
20.80
|
13.21
|
3.04
|
30.84
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
24.74
|
17.39
|
19.69
|
26.20
|
25.37
|
7.96
|
|||||
|
Price / Book Value
|
4.14
|
3.23
|
3.72
|
5.10
|
2.84
|
2.10
|
|||||
|
Dividend Yield (%)
|
0.09
|
0.11
|
1.24
|
0.30
|
1.22
|
0.72
|
|||||
|
EV/EBITDA
|
13.90
|
10.91
|
12.15
|
17.78
|
12.44
|
10.88
|
|||||
|
Close Price (₹)
|
1,112.60
|
871.20
|
886.40
|
1,007.35
|
491.55
|
348.50
|
|||||
|
High Price (₹)
|
1,128.50
|
1,059.05
|
1,324.30
|
1,030.15
|
494.95
|
673.70
|
|||||
|
Low Price (₹)
|
835.50
|
795.00
|
855.10
|
482.55
|
319.00
|
331.00
|
|||||
|
Market Cap (₹ Cr)
|
1,11,670.55
|
87,643.18
|
89,100.94
|
1,01,128.47
|
49,740.24
|
35,706.88
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.12
|
0.43
|
0.13
|
0.04
|
0.07
|
0.25
|
|||||
|
Short term debt to equity ratio
|
--
|
0.16
|
0.13
|
0.04
|
0.06
|
0.19
|
|||||
|
Current Ratio
|
1.27
|
1.27
|
1.89
|
2.14
|
1.81
|
1.55
|
|||||
|
Quick Ratio
|
0.91
|
0.91
|
1.45
|
1.50
|
1.19
|
1.07
|
|||||
|
Interest Coverage
|
12.77
|
16.09
|
32.55
|
60.22
|
20.94
|
23.35
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.94
|
19.95
|
17.58
|
26.71
|
25.62
|
22.11
|
|||||
|
Asset Turnover
|
0.64
|
1.21
|
1.46
|
1.46
|
1.32
|
1.19
|
|||||
|
Receivable days
|
--
|
33.55
|
37.17
|
46.37
|
41.75
|
39.94
|
|||||
|
Inventory Days
|
--
|
33.80
|
29.51
|
32.98
|
38.39
|
42.95
|
|||||
|
Payable days
|
--
|
149.82
|
150.48
|
147.51
|
145.80
|
166.64
|
|||||
|
Cash Conversion Cycle
|
--
|
-82.46
|
-83.79
|
-68.16
|
-65.67
|
-83.76
|